» Articles » PMID: 25038968

Using Genes to Facilitate the Endogenous Repair and Regeneration of Orthopaedic Tissues

Overview
Journal Int Orthop
Specialty Orthopedics
Date 2014 Jul 21
PMID 25038968
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional tissue engineering approaches to the restoration of orthopaedic tissues promise to be expensive and not well suited to treating large numbers of patients. Advances in gene transfer technology offer the prospect of developing expedited techniques in which all manipulations can be performed percutaneously or in a single operation. This rests on the ability of gene delivery to provoke the sustained synthesis of relevant gene products in situ without further intervention. Regulated gene expression is also possible, but its urgency is reduced by our ignorance of exactly what levels and periods of expression are needed for specific gene products. This review describes various strategies by which gene therapy can be used to expedite the repair and regeneration of orthopaedic tissues. Strategies include the direct injection of vectors into sites of injury, the use of genetically modified, allogeneic cell lines and the intra-operative harvest of autologous tissues that are quickly transduced and returned to the body, either intact or following rapid cell isolation. Data obtained from pre-clinical experiments in animal models have provided much encouragement that such approaches may eventually find clinical application in human and veterinary medicine.

Citing Articles

Gene Therapy for Regenerative Medicine.

Hosseinkhani H, Domb A, Sharifzadeh G, Nahum V Pharmaceutics. 2023; 15(3).

PMID: 36986717 PMC: 10057434. DOI: 10.3390/pharmaceutics15030856.


New frontiers of tendon augmentation technology in tissue engineering and regenerative medicine: a concise literature review.

Makuku R, Werthel J, Zanjani L, Nabian M, Tantuoyir M J Int Med Res. 2022; 50(8):3000605221117212.

PMID: 35983666 PMC: 9393707. DOI: 10.1177/03000605221117212.


Current and future trends in periodontal tissue engineering and bone regeneration.

Galli M, Yao Y, Giannobile W, Wang H Plast Aesthet Res. 2022; 8.

PMID: 35765666 PMC: 9236184. DOI: 10.20517/2347-9264.2020.176.


Bioengineering Approaches to Accelerate Clinical Translation of Stem Cell Therapies Treating Osteochondral Diseases.

Wang M, Luo Y, Yu Y, Chen F Stem Cells Int. 2021; 2020:8874742.

PMID: 33424981 PMC: 7775142. DOI: 10.1155/2020/8874742.


Mohawk is a transcription factor that promotes meniscus cell phenotype and tissue repair and reduces osteoarthritis severity.

Lee K, Gamini R, Olmer M, Ikuta Y, Hasei J, Baek J Sci Transl Med. 2020; 12(567).

PMID: 33115953 PMC: 7955769. DOI: 10.1126/scitranslmed.aan7967.


References
1.
Goodrich L, Hidaka C, Robbins P, Evans C, Nixon A . Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br. 2007; 89(5):672-85. DOI: 10.1302/0301-620X.89B5.18343. View

2.
Evans C . Potential biologic therapies for the intervertebral disc. J Bone Joint Surg Am. 2006; 88 Suppl 2:95-8. DOI: 10.2106/JBJS.E.01328. View

3.
Orth P, Kaul G, Cucchiarini M, Zurakowski D, Menger M, Kohn D . Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg Sports Traumatol Arthrosc. 2011; 19(12):2119-30. DOI: 10.1007/s00167-011-1448-6. View

4.
Cucchiarini M, Madry H, Ma C, Thurn T, Zurakowski D, Menger M . Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther. 2005; 12(2):229-38. DOI: 10.1016/j.ymthe.2005.03.012. View

5.
Evans C, Ghivizzani S, Robbins P . The 2003 Nicolas Andry Award. Orthopaedic gene therapy. Clin Orthop Relat Res. 2004; (429):316-29. DOI: 10.1097/01.blo.0000148854.14399.ec. View